Search

Gimv NV

Slēgts

SektorsFinanšu

46.35 3.23

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

44.5

Max

46.35

Galvenie mērījumi

By Trading Economics

Ienākumi

127M

Pārdošana

-49M

65M

P/E

Sektora vidējais

7.821

28.186

EPS

3.4

Dividenžu ienesīgums

5.68

Peļņas marža

195.239

Darbinieki

94

EBITDA

52M

128M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.68%

4.24%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

77M

1.7B

Iepriekšējā atvēršanas cena

43.12

Iepriekšējā slēgšanas cena

46.35

Ziņu noskaņojums

By Acuity

50%

50%

180 / 493 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. janv. 22:41 UTC

Iegādes, apvienošanās, pārņemšana

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

2026. g. 15. janv. 00:00 UTC

Peļņas

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

2026. g. 14. janv. 23:47 UTC

Tirgus saruna

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

2026. g. 14. janv. 23:44 UTC

Tirgus saruna

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

2026. g. 14. janv. 23:39 UTC

Tirgus saruna

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

2026. g. 14. janv. 23:32 UTC

Tirgus saruna

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026. g. 14. janv. 22:56 UTC

Iegādes, apvienošanās, pārņemšana

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

2026. g. 14. janv. 22:53 UTC

Iegādes, apvienošanās, pārņemšana

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

2026. g. 14. janv. 22:09 UTC

Peļņas

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

2026. g. 14. janv. 21:52 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Announces Positive Profit Alert for 2025

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Citigroup Acting as Financial Advisor to WuXi XDC

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Aims to Keep Listing Status of BioDlink

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

2026. g. 14. janv. 21:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2026. g. 14. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 14. janv. 21:49 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: BioDlink Offer to Cost HK$2.79B

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Makes Cash Offer for BioDlink International

2026. g. 14. janv. 21:13 UTC

Tirgus saruna

Oil Retreats Late After Trump Comments on Iran -- Market Talk

2026. g. 14. janv. 20:30 UTC

Tirgus saruna
Peļņas

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

2026. g. 14. janv. 20:13 UTC

Tirgus saruna

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

2026. g. 14. janv. 20:08 UTC

Tirgus saruna

Oil Futures Extend Rally on Iran Tensions -- Market Talk

2026. g. 14. janv. 19:33 UTC

Tirgus saruna

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

2026. g. 14. janv. 19:06 UTC

Tirgus saruna
Peļņas

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

180 / 493 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat